Re: "Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies" by Sicco et al
Related Experiment Videos
Luca Filippi1, Oreste Bagni1, Orazio Schillaci2,3
1Department of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy.
Cancer Biotherapy & Radiopharmaceuticals
|July 10, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
PSMA-Targeted Theranostics in Glioblastoma Multiforme: Current Evidence and Future Perspectives.
International journal of molecular sciences·2026
Prognostic relevance of [18F]FDG PET/CT in triple-negative breast cancer: Results from the triple negative (TRINE)-PET trial.
European journal of nuclear medicine and molecular imaging·2026
Mapping the Synaptome in Neurodegeneration: Emerging Clinical Applications of SV2A PET Imaging.
Molecular diagnosis & therapy·2026
Synergistic Effects of Ultrasound and Lenvatinib on Proliferation Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Cells.
Cancer biotherapy & radiopharmaceuticals·2026
Ultrasound-Mediated Modulation of circRNA hsa_circ_0004870 as a Prognostic and Therapeutic Biomarker in Pancreatic Cancer.
Cancer biotherapy & radiopharmaceuticals·2026
A Hierarchical Framework for Autonomous Macrophage Migration Based on Exploration and Exploitation.
Cancer biotherapy & radiopharmaceuticals·2026
Radioimmunotherapy: Mechanisms, Strategies, and Advances in Therapeutic Enhancement.
Cancer biotherapy & radiopharmaceuticals·2026
Focused Ultrasound-Enhanced Delivery of ED5, a CK1α-Targeting Oleanolic Acid Analogue, Suppresses Glioma Growth via MAPK-ROS-ERS Pathway Modulation.
Cancer biotherapy & radiopharmaceuticals·2026
Theranostic Radiopharmaceutical-Guided Robotic Surgery for Precision Tumor Resection and Targeted Elimination of Residual Disease in Digestive System Malignancies.
Cancer biotherapy & radiopharmaceuticals·2026
G-quadruplex ligand-mediated CHK1 and ERα suppression in endocrine-sensitive and endocrine-resistant luminal breast cancer cells.
Cell cycle (Georgetown, Tex.)·2026
Obeticholic acid: discovery, clinical translation, and regulatory withdrawal.
European review for medical and pharmacological sciences·2026
An Act of DeFianCe: Targeting DKK1 in Metastatic Colorectal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Cardiac toxicity and dysrhythmias in acute poisoning: a ten-year cohort study.
Clinical toxicology (Philadelphia, Pa.)·2026